Všetko, na čom vám záleží, na jednom mieste
Sledujte feedy: blogy, správy, RSS a ďalší obsah. Jednoduchý spôsob, ako čítať a spracovať obsah podľa vlastného výberu.
Získať FeederRSS feedy pre Onkológia
Kanály RSS pre Onkológia, ktoré používatelia Feeder sledujú najviac, vrátane ClinicalTrials.gov: "ONCOLOGY" | Phase: Early Phase 1, 1, 2, 3 | First posted on or after 05/13/2025 | First posted in the last 14 days, Outpace Bio News a Oncoinvent News and Events. Skopírujte adresu URL kanála alebo ich sledujte bezplatne vo Feeder.
Súvisiace témy
RSS feedy pre Zdravie RSS feedy pre Klinické skúšania RSS feedy pre Lekársky výskum RSS feedy pre Duševné zdravie RSS feedy pre Psychológia RSS feedy pre Verejné zdravie RSS feedy pre Farmaceutický priemysel
Navrhnúť úpravuClinicalTrials.gov: "ONCOLOGY" | Phase: Early Phase 1, 1, 2, 3 | First posted on or after 05/13/2025 | First posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: "ONCOLOGY" | Phase: Early Phase 1, 1, 2, 3 | First posted on or after 05/13/2025 | First posted in the last 14 days
Oncodesign Services Resources
Nature Reviews Drug Discovery AND cancer
Nature Reviews Drug Discovery AND cancer: Latest results from PubMed
ClinicalTrials.gov: Other terms: HER-2/HER2 | Antibody-drug conjugate \(ADC\) | Funded by Industry | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Other terms: HER-2/HER2 | Antibody-drug conjugate \(ADC\) | Funded by Industry | Last update posted in the last 14 days
ClinicalTrials.gov: Other terms: "TCE" OR "T Cell Engager" OR "T-Cell Engager" | Interventional studies | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Other terms: "TCE" OR "T Cell Engager" OR "T-Cell Engager" | Interventional studies | Last update posted in the last 14 days
Frontiers in Oncology | New and Recent Articles
RSS Feed for Frontiers in Oncology | New and Recent Articles
ScienceDirect Publication: Nuclear Medicine and Biology
ScienceDirect RSS
bioRxiv Subject Collection: Cancer Biology
This feed contains articles for bioRxiv Subject Collection "Cancer Biology"
ClinicalTrials.gov: Other terms: KRAS G12D | Funded by Industry | First posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Other terms: KRAS G12D | Funded by Industry | First posted in the last 14 days
ClinicalTrials.gov: Other terms: KRAS | Funded by Industry | First posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Other terms: KRAS | Funded by Industry | First posted in the last 14 days
ClinicalTrials.gov: Other terms: CEA | Funded by Industry | First posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Other terms: CEA | Funded by Industry | First posted in the last 14 days
ClinicalTrials.gov: "cervical cancer" | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: "cervical cancer" | Last update posted in the last 14 days
ClinicalTrials.gov: TAK228 | Studies updated in the last 14 days
Studies found on ClinicalTrials.gov by a search of: TAK228 | Last update posted in the last 14 days
Business Wire - News by Company: Incyte Corporation
Business Wire - The global leader in news distribution
Cancer Currents: An NCI Cancer Research Blog
<p>A blog featuring news and research updates from the National Cancer Institute.</p>
Annual Reviews: Annual Review of Cancer Biology: Table of Contents
Please follow the links to view the content.
medrxiv Subject Collection: Oncology
This feed contains articles for medRxiv Subject Collection "Oncology"
ClinicalTrials.gov: cetrelimab | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: cetrelimab | Last update posted in the last 14 days
ClinicalTrials.gov: toripalimab | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: toripalimab | Last update posted in the last 14 days
ClinicalTrials.gov: tislelizumab | First posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: tislelizumab | First posted in the last 14 days
Cancer Gene Therapy
<em>Cancer Gene Therapy</em> is the essential gene and cellular therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene and cellular therapies for cancer. Publication topics include RNAi approaches, drug resistance, hematopoietic progenitor cell gene transfer, cancer stem cells, cellular therapies, homologous recombination, ribozyme technology, antisense technology, tumor immunotherapy and tumor suppressors, translational research, cancer therapy, gene delivery systems (viral and non-viral), anti-gene therapy (antisense, siRNA & ribozymes), apoptosis; mechanisms and therapies, vaccine development, immunology and immunotherapy, DNA synthesis and repair. <em>Cancer Gene Therapy</em> publishes the results of laboratory investigations, preclinical studies, and clinical trials in the field of gene transfer/gene therapy and cellular therapies as applied to cancer research. Articles published include the fields of drug resist
ClinicalTrials.gov: enfortumab | First posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: enfortumab | First posted in the last 14 days
ClinicalTrials.gov: enfortumab | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: enfortumab | Last update posted in the last 14 days
ClinicalTrials.gov: SKB410 | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: SKB410 | Last update posted in the last 14 days
ClinicalTrials.gov: CRB-701 | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: CRB-701 | Last update posted in the last 14 days
ClinicalTrials.gov: LY4052031 | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: LY4052031 | Last update posted in the last 14 days
ClinicalTrials.gov: MK-3120 | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: MK-3120 | Last update posted in the last 14 days
ClinicalTrials.gov: Cervical Cancer | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Cervical Cancer | Last update posted in the last 14 days
ClinicalTrials.gov: ovarian | Not yet recruiting, Recruiting studies | Phase: 2, 3 | Interventional studies | Study start on or after 01/01/2023 | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: ovarian | Not yet recruiting, Recruiting studies | Phase: 2, 3 | Interventional studies | Study start on or after 01/01/2023 | Last update posted in the last 14 days
ClinicalTrials.gov: Other terms: Pfizer | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Other terms: Pfizer | Last update posted in the last 14 days
ClinicalTrials.gov: Other terms: Sanofi | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Other terms: Sanofi | Last update posted in the last 14 days